Changes in rat urinary porphyrin profiles predict the magnitude of the neurotoxic effects induced by a mixture of lead, arsenic and manganese

NeuroToxicology

Volumn 45, Issue , 2014, Pages 168-177

  Andrade, Vanda ^a   Mateus, M Luísa ^a   Batoréu, M Camila ^a   Aschner, Michael ^b   Marreilha dos Santos, A P ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Lead, arsenic and manganese metal mixture; Neurotoxicity; Urinary porphyrin profiles

Indexed keywords

ARSENIC; LEAD; MANGANESE; PORPHYRIN; BIOLOGICAL MARKER; HEAVY METAL;

ACCURACY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; ENZYME ANALYSIS; MALE; MOTOR ACTIVITY; MOTOR DYSFUNCTION; NEUROTOXICITY; NONHUMAN; PREDICTION; RAT; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; URINE LEVEL; WISTAR RAT; ANIMAL; BRAIN CHEMISTRY; DIAGNOSTIC USE; DRUG EFFECTS; INTOXICATION; NEUROTOXICITY SYNDROMES; URINE;

RATTUS;

ANIMALS; ARSENIC; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; LEAD; MALE; MANGANESE; METALS, HEAVY; MOTOR ACTIVITY; NEUROTOXICITY SYNDROMES; POISONING; PORPHYRINS; RATS; RATS, WISTAR;

EID: 84911400324     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.10.009     Document Type: Article

References (72)

1. Ahmed S.S.J., Santos W., Kumar S., Christlet H.T.T. Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection. J Biomed Sci 2009, 16(63):1-12.
2. Akobeng A.K. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007, 96(5):644-647.
3. Andrade V., Mateus M.L., Santos D., Aschner M., Batoreu M.C., Marreilha dos Santos A.P. Arsenic and manganese alter lead deposition in the rat. Biol Trace Elem Res 2014, 158(3):384-391.
4. Andrade V., Mateus M.L., Batoréu M.C., Aschner M., Marreilha dos Santos A.P. Urinary delta-ALA: a potential biomarker of exposure and neurotoxic effect in rats co-treated with a mixture of lead, arsenic and manganese. NeuroToxicology 2013, 11(38):33-41.
5. Araki S. Effects of urinary volume on urinary concentrations of lead, 6-aminolaevulinic acid, coproporphyrin, creatinine, and total solutes. Br J Ind Med 1980, 37:50-54.
6. ATSDR a.U.S.Department of Health and Human Services, Public Health Service Agency for Toxic Substances and Disease Registry Arsenic compounds 2012, U.S. Department of Health and Human Services, Public Health Service Agency for Toxic Substances and Disease Registry, http://www.epa.gov/ttnatw01/hlthef/arsenic.html (6 Oct 2014).
7. ATSDR b.U.S.Department of Health and Human Services, Public Health Service Agency for Toxic Substances and Disease Registry Toxicological profile for manganese. CAS# 7439-96-5 2007, http://www.atsdr.cdc.gov/toxprofiles (25 Feb 2013).
8. Bernard A. Biomarkers of metal toxicity in population studies: research potential and interpretation issues. J Toxicol Environ Health 2008, 71(18):1259-1265.
9. Bowers M.A., Aicher L.D., Davis H.A., Woods J.S. Quantitative determination of porphyrins in rat and human urine and evaluation of urinary porphyrin profiles during mercury and lead exposures. J Lab Clin Med 1992, 120(2):272-281.
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1986, 72:248-254.
11. Calderon J., Ortiz-Perez D., Yanez L., Díaz-Barriga F. Human exposure to metals. Pathways of exposure, biomarkers of effect, and host factors. Ecotoxicol Environ Saf 2003, 56:93-103.
12. Cohn J.A., Alvares A.P., Kappas A. On the occurrence of cytochrome P450 and aryl hydrocarbon hydroxylase activity in rat brain. J Exp Med 1977, 145:1607-1611.
13. Costa L.G., Manzo L. Biochemical markers of neurotoxicity: research epidemiological applications. Toxicol Lett 1995, 77(1-3):137-144.
14. Da X., Toledo J.B., Zee J., Wolk D.A., Xie S.X., Ou Y., et al. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers. NeuroImage: Clin 2014, 4:164-173.
15. Dhatrak S.V., Nandi S.S. Risk assessment of chronic poisoning among Indian metallic miners. Indian J Occup Environ Med 2009, 13(2):60-64.
16. Dukhande V.V., Malthankar-Phatak G.H., Hugus J.J., Daniels C.K., Lai J.C.K. Manganese-induced neurotoxicity is differentially enhanced by glutathione depletion in astrocytoma and neuroblastoma cells. Neurochem Res 2006, 31:1349-1357.
17. Edgell T., Martin-Roussety G., Barker G., Autelitano D.J., Allen D., Grant P., et al. Phase II biomarker trial of a multimarker diagnostic for ovarian cancer. J Cancer Res Clin Oncol 2010, 136(7):1079-1088.
18. Ennis S.R., Novotny A., Xiang J., Shakui P., Masada T., Stummer W., et al. Transport of 5-aminolevulinic acid between blood and brain. Brain Res 2003, 959:226-234.
19. Feldman D.S., Levere R.D., Lieberman J.S., Cardinal R.A., Watson C.J. Presynaptic neuromuscular inhibition by porphobilinogen and porphobilin. Proc Natl Acad Sci USA 1971, 68:383-386.
20. Flora S.J.S. Arsenic-induced oxidative stress and its reversibility. Free Rad Biol Med 2011, 51:257-281.
21. Fowler B.A., Kimmel C.A., Woods J.S., McConnell E.E., Grant L.D. Chronic low-level lead toxicity in the rat. III. An integrated assessment of long-term toxicity with specific reference to the kidney. Toxicol Appl Pharmacol 1980, 56:59-77.
22. Fowler B.A., Mahaffey K.R. Interactions among lead, cadmium, and arsenic in relation to porphyrin excretion patterns. Environ Health Perspect 1978, 25:87-90.
23. Fowler B.A., Oskarsson A., Woods J.S. Metal- and metalloid-induced porphyrinurias: relationships to cell injury. Ann NY Acad Sci 1987, 514:172-182.
24. Fujita H., Nishitani C., Ogawa K. Lead: chemical porphyria, and heme as a biological mediator. Tohoku J Exp Med 2002, 196(2):53-64.
25. García S.C., Moretti M.B., Garay M.V.R., Batlle A. Delta-aminolevulinic acid transport through blood-brain barrier. Gen Pharmacol 1998, 31(4):579-582.
26. García-Vargas G.G., Del Razo L.M., Cebrián M.E., Albores A., Ostrosky-Wegman P., Montero R., et al. Altered urinary porphyrin excretion in a human population chronically exposed to arsenic in Mexico. Hum Exp Toxicol 1994, 13(12):839-847.
27. García-Vargas G.G., Hernández-Zavala A. Urinary porphyrins and heme biosynthetic enzyme activities measured by HPLC in arsenic toxicity. Biomed Chromatogr 1996, 10(6):278-284.
28. Halatek T., Sinczuk-Walczak H., Rabieh S., Wasowicz W. Association between occupational exposure to arsenic and neurological, respiratory and renal effects. Toxicol Appl Pharmacol 2009, 239:193-199.
29. Harada K., Miura H. Free erythrocyte protoporphyrin (FEP) and zinc protoporphyrin (ZnP) as biological parameters for lead poisoning. Int Arch Occup Environ Health 1984, 53(4):365-377.
30. Health Canada, Water, Air & Climate Change Bureau Human health risk assessment for inhaled manganese draft 2008, Health Canada, Water, Air & Climate Change Bureau.
31. Juknat A.A., Kotler M.L., Batlle A.M. High 6-aminolevulinic acid uptake in rat cerebral cortex: effect on porphyrin biosynthesis. Comp Biochem Physiol 1995, 111C(1):143-150.
32. Kannan G.M., Tripathi N., Dube S.N., Gupta M., Flora S.J. Toxic effects of arsenic(III) on some hematopoietic and central nervous system variables in rats and guinea pigs. J Toxicol Clin Toxicol 2001, 39(7):675-682.
33. Kauppinen R. Porphyrias. Lancet 2005, 365:241-252.
34. Krishnamohan M., Qi L., Lam P.K.S., Moore M.R., Ng J.C. Urinary arsenic and porphyrin profile in C57BL/6J mice chronically exposed to monomethylarsonous acid (MMAIII) for two years. Toxicol Appl Pharmacol 2007, 224:89-97.
35. Kulig B., Alleva E., Bignami G., Cohn J., Cory-Slechta D., Landa V., et al. Animal behavioral methods in neurotoxicity assessment. Environ Health Perspect 1996, 104(2):193-204.
36. Loots J.M., Becker D.M., Meyer B.J., Goldstuck N., Kramer S. The effect of porphyrin precursors on monosynaptic reflex activity in the isolated hemisected frog spinal cord. J Neural Transm 1975, 36(1):71-81.
37. McMillan D.E. Risk assessment for neurobehavioral toxicity. Environ Health Perspect 1987, 76:155-161.
38. Mahaffey K.R., Capar S.G., Gladen B.C., Fowler B.A. Concurrent exposure to lead, cadmium and arsenic. Effects on toxicity and tissue metal concentrations in the rat. J Lab Clin Med 1981, 98:463-481.
39. Maines M.D. Regional distribution of the enzymes of haem biosynthesis and the inhibition of 5-aminolaevulinate synthase by manganese in the rat brain. Biochem J 1980, 190:315-321.
40. Mameli O., Caria M.A., Melis F., Solinas A., Tavera C., Ibba A., et al. Neurotoxic effect of lead at low concentrations. Brain Res Bull 2001, 55(2):269-275.
41. Marks G.S. Exposure to toxic agents: the heme biosynthetic pathway and hemoproteins as indicators. CRC Crit Rev Toxicol 1985, 15:151-179.
42. Maroco J. Análise estatística com a utilização do SPSS. Edições Sílabo 2003, Lisboa. 1 Ed.
43. Marreilha dos Santos A.P., Lucas R.L., Andrade V., Mateus M.L., Milatovic D., Aschner M., et al. Protective effects of ebselen (Ebs) and para-aminosalicylic acid (PAS) against manganese (Mn)-induced neurotoxicity. Toxicol Appl Pharmacol 2012, 258(3):394-402.
44. Martinez-Finley E.J., Chakraborty S., Fretham S.J.B., Aschner M. Cellular transport and homeostasis of essential and nonessential metals. Metallomics 2012, 4(7):593-605.
45. Mejía J.J., Dáz-Barriga F., Calderón J., Ríos C., Jiménez-Capdeville M.E. Effects of lead-arsenic combined exposure on central monoaminergic systems. Neurotoxicol Teratol 1997, 19(6):489-497.
46. Novotnya A., Stummer W. 5-Aminolevulinic acid and the blood-brain barrier-a review. Med Laser Appl 2003, 18(1):36-40.
47. Paterniti J.R., Simone J.J., Beattie D.S. Detection and regulation of delta-aminolevulinic acid synthetase activity in the rat brain. Arch Biochem Biophys 1978, 189(1):86-91.
48. Patrick L. Lead toxicity, a review of the literature. Part I: Exposure, evaluation, and treatment. Altern Med Rev 2006, 11(1):2-22.
49. Prakash A., Athanas M., Sarracino D., Krastins B., Rezai T., Lope M. Efficiently generating multi biomarker ROC curves to identify significant multi biomarkers 2010, https://fscimage.fishersci.com/images/D00345 (11th April 2014).
50. Princ F.G., Juknat A.A., Amitrano A.A., Batlle A. Effect of reactive oxygen species promoted by d-aminolevulinic acid on porphyrin biosynthesis and glucose uptake in rat cerebellum. Gen Pharmacol 1998, 31(1):143-148.
51. Quinones M.P., Kaddurah-Daouk R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis 2009, 35:165-176.
52. Quintanilla-Vega B., Hernandez A., Mendoza-Figueroa T. Reduction in porphyrin excretion as a sensitive indicator of lead toxicity in primary cultures of adult rat hepatocytes. Toxicol In Vitro 1996, 10:675-683.
53. Ravid R. Biobanks for biomarkers in neurological disorders: the Da Vinci bridge for optimal clinico-pathological connection. J Neurol Sci 2009, 283:119-126.
54. Reckziegel P., Dias V.T., Benvegnú D., Boufleur N., Barcelos R.C.S., Segat H.J., et al. Locomotor damage and brain oxidative stress induced by lead exposure are attenuated by gallic acid treatment. Toxicol Lett 2011, 203:74-81.
55. Reddy G.R., Basha R., Devi C.B., Suresh A., Baker J.L., Shafeek A., et al. Lead induced effects on acetylcholinesterase activity in cerebellum and hippocampus of developing rat. Int J Dev Neurosci 2003, 21:347-352.
56. Rodríguez V.M., Limón-Pacheco J.H., Carrizales L., Mendoza-Trejo M.S., Giordano M. Chronic exposure to low levels of inorganic arsenic causes alterations in locomotor activity and in the expression of dopaminergic and antioxidant systems in the albino rat. Neurotoxicol Teratol 2010, 32(6):640-647.
57. Sansar W., Ahboucha S., Gamrani H. Chronic lead intoxication affects glial and neural systems and induces hypoactivity in adult rat. Acta Histochem 2011, 113:601-607.
58. Santamaria A.B. Manganese exposure, essentiality & toxicity. Indian J Med Res 2008, 128:484-500.
59. Santos D., Milatovic D., Andrade V., Batoréu M.C., Aschner M., Marreilha dos Santos A.P. The inhibitory effect of manganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the rat brain. Toxicology 2012, 292(2-3):90-98.
60. Scherer G. Biomonitoring of inhaled complex mixtures-ambient air, diesel exhaust and cigarette smoke. Exp Toxicol Pathol 2005, 57:75-110.
61. Shin S., Coulter B., San Diego C.A. ROC analysis for the evaluation of continuous biomarkers: existing tools and new features in SAS® 9.2 2009, http://pharmasug.org/download/papers/SP09 (25 Feb 2014).
62. Simon N.G., Herkes G.K. The neurologic manifestations of the acute porphyrias. J Clin Neurosci 2011, 18:1147-1153.
63. Søreide K. Receiver-operating characteristic (ROC) curve analysis in diagnostic: prognostic and predictive biomarker research. J Clin Pathol 2009, 62(1):1-5.
64. Tiffany-Castiglioni E., Hong S., Qian Y., Tang Y., Donnelly K.C. In vitro models for assessing neurotoxicity of mixtures. NeuroToxicol 2006, 27:835-839.
65. Toscano C.D., Guilarte T.R. Lead neurotoxicity: from exposure to molecular effects. Brain Res Rev 2005, 49:529-554.
66. Yadav R.S., Sankhwar M.L., Shukla R.K., Chandra R., Pant A.B., Islamb F., et al. Attenuation of arsenic neurotoxicity by curcumin in rats. Toxicol Appl Pharmacol 2009, 240:367-376.
67. Wang G., Fowler B.A. Roles of biomarkers in evaluating interactions among mixtures of lead, cadmium and arsenic. Toxicol Appl Pharmacol 2008, 233:92-99.
68. Warnock D.G., Peck C.P. A roadmap for biomarker qualification. Nat Biotechnol 2010, 28:444-445.
69. Woods J.S., Bowers M.A., Davis H.A. Urinary porphyrin profiles as biomarkers of trace metal exposure and toxicity: studies on urinary porphyrin excretion patterns in rats during prolonged exposure to methyl mercury. Toxicol Appl Pharmacol 1991, 110(3):464-476.
70. Woods J.S., Martin M.D., Leroux B.G., DeRouen T.A., Bernardo M.F., Luis H.S., Leitão J.G., et al. Simmonds PL, and Rue TC. Urinary porphyrin excretion in normal children and adolescents. Clin Chim Acta 2009, 405:104-109.
71. Wright R.O., Baccarelli A. Metals and neurotoxicology. J Nutr 2007, 137(12):2809-2813.
72. Wu H., Manonmaniia K., Lamb P.K.S., Huanga S.H., Wanga J.P., Ng J.C. Urinary arsenic speciation and porphyrins in C57Bl/6J mice chronically exposed to low doses of sodium arsenate. Toxicol Lett 2004, 154:149-157.